Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines
about
Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for advanced and/or metastatic colorectal cancerIrinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for advanced and/or metastatic colorectal cancerSafety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer.A review of oxaliplatin and its clinical use in colorectal cancer.Increasing doxorubicin activity against breast cancer cells using PPARγ-ligands and by exploiting circadian rhythmsCurcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis.The efficacy and safety of hepatic arterial infusion of oxaliplatin plus intravenous irinotecan, leucovorin and fluorouracil in colorectal cancer with inoperable hepatic metastasis.Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan.First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule.Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines.Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro.
P2860
Q24200737-C2159932-2FB2-4660-AA95-57D7E4907D15Q24234555-F394A23D-9CED-4D7D-AB89-D5F532E25E6DQ35076251-2243E290-68DE-4518-B8BD-32E13C2EA981Q35906940-0AF12701-4CF4-4409-97A4-F6ABA9D43F6BQ36965932-A2FE5B48-39BB-487B-8716-B24D490B946BQ38938309-87013643-F836-41CB-A697-4F64D5F80C9FQ41713124-8A992223-5EC9-44CD-8D07-7499B12C0C62Q41967128-B3A2BAF3-0748-4A29-AD8C-AD4DC9945982Q45154772-8D3B19F6-F523-4485-8368-5C71184509F8Q46231667-C2295826-7C82-4809-A3DB-9D82BB16D737Q47106034-BAF322A3-0064-4761-B7BA-6AA1FF5EFF64Q48315153-855BEB92-3A60-4890-A459-1BDDEEAD5ABD
P2860
Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Ternary combination of irinote ...... human colon cancer cell lines
@ast
Ternary combination of irinote ...... human colon cancer cell lines
@en
Ternary combination of irinote ...... human colon cancer cell lines
@nl
type
label
Ternary combination of irinote ...... human colon cancer cell lines
@ast
Ternary combination of irinote ...... human colon cancer cell lines
@en
Ternary combination of irinote ...... human colon cancer cell lines
@nl
prefLabel
Ternary combination of irinote ...... human colon cancer cell lines
@ast
Ternary combination of irinote ...... human colon cancer cell lines
@en
Ternary combination of irinote ...... human colon cancer cell lines
@nl
P2093
P2860
P356
P1476
Ternary combination of irinote ...... human colon cancer cell lines
@en
P2093
A Dubreuil
J L Fischel
M C Etienne
P Formento
P Rostagno
P2860
P2888
P304
P356
10.1054/BJOC.2000.1600
P407
P577
2001-02-01T00:00:00Z
P5875
P6179
1006679595